LAVA Medtech Acquisition (LAVA Medtech Acquisition) EBIT : $-1.56 Mil (TTM As of Dec. 2022)

View and export this data going back to 2021. Start your Free Trial

What is LAVA Medtech Acquisition EBIT?

LAVA Medtech Acquisition's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2022 was $-0.38 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2022 was $-1.56 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. LAVA Medtech Acquisition's annualized ROC % for the quarter that ended in Dec. 2022 was -1.10%. LAVA Medtech Acquisition's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2022 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

LAVA Medtech Acquisition EBIT Historical Data

The historical data trend for LAVA Medtech Acquisition's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Medtech Acquisition EBIT Chart

LAVA Medtech Acquisition Annual Data

Trend

Dec21

Dec22

EBIT

-1.56

LAVA Medtech Acquisition Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
EBIT	Get a 7-Day Free Trial			-0.29	-0.46	-0.35	-0.38	-0.38

Competitive Comparison of LAVA Medtech Acquisition's EBIT

For the Shell Companies subindustry, LAVA Medtech Acquisition's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LAVA Medtech Acquisition's EV-to-EBIT Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, LAVA Medtech Acquisition's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where LAVA Medtech Acquisition's EV-to-EBIT falls into.

LAVA Medtech Acquisition EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.56 Mil.

LAVA Medtech Acquisition (NAS:LVACW) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

LAVA Medtech Acquisition's annualized ROC % for the quarter that ended in Dec. 2022 is calculated as:

	ROC % (Q: Dec. 2022 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2022 )	+	Invested Capital (Q: Dec. 2022 ))	/ count )
=	-1.512 * ( 1 - 13.81% )	/	( (118.581	+	119.382)	/ 2 )
=	-1.3031928	/	118.9815
=	-1.10 %

where

	Invested Capital		(Q: Sep. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	120.091	-	0.514	-	( 1.13	-	max(0, 0.514	-	1.51	+	1.13	))
=	118.581

	Invested Capital		(Q: Dec. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	120.667	-	4.678	-	( 1.159	-	max(0, 4.76	-	1.367	+	1.159	))
=	119.382

Note: The Operating Income data used here is four times the quarterly (Dec. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

LAVA Medtech Acquisition's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2022 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2022 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2022		Q: Dec. 2022
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-1.512	/	( ( (0 + max(-0.134, 0))	+	(0 + max(-4.552, 0)) )	/	2 )
=	-1.512	/	( ( 0	+	0 )	/	2 )
=	-1.512	/	0
=	%

where Working Capital is:

	Working Capital		(Q: Sep. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.38)	-	(0.514	+	0	+	0)
=	-0.134

	Working Capital		(Q: Dec. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.208)	-	(4.678	+	0	+	0.082)
=	-4.552

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

LAVA Medtech Acquisition's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2022 )
	=	-1.56	/	0.000
	=	%

LAVA Medtech Acquisition EBIT Related Terms

Thank you for viewing the detailed overview of LAVA Medtech Acquisition's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.